Glenmark Pharmaceuticals consolidated net profit rises 10.09% in the September 2021 quarter

Sales rise 7.47% to Rs 3125.43 crore

Net profit of Glenmark Pharmaceuticals rose 10.09% to Rs 257.66 crore in the quarter ended September 2021 as against Rs 234.04 crore during the previous quarter ended September 2020. Sales rose 7.47% to Rs 3125.43 crore in the quarter ended September 2021 as against Rs 2908.12 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales3125.432908.12 7 OPM %18.8819.01 -PBDT508.15440.30 15 PBT384.96336.24 14 NP257.66234.04 10

Powered by Capital Market - Live News